
Addressing the Unmet Needs of Refractory Chronic Cough
Chronic cough can significantly impact patients’ quality of life, and refractory chronic cough (RCC) continues to present diagnostic and therapeutic challenges for health care professionals. This online CME activity will explore the latest evidence and evolving approaches to RCC, including guideline-based diagnostic strategies, the underlying neurobiology of cough hypersensitivity, and emerging targeted therapies.
Learners will gain practical insights to help recognize RCC, better understand its underlying mechanisms, and evaluate advances in clinical research that may shape future treatment options. Join this educational activity to strengthen your clinical knowledge and support improved care for patients living with RCC.
Target Audience
US-based healthcare professionals who care for patients with RCC, including pulmonologists, allergists, otolaryngologists, primary care providers, nurse practitioners, physician assistants, and speech pathologists.
Learning Objectives
Upon completion of this course, the learners should be able to:
- Summarize best practices for the diagnosis of RCC in conjunction with current evidence-based guidelines
- Describe the underlying pathophysiology of RCC in accordance with current understanding of the mechanisms involved in cough hypersensitivity
- Assess ongoing developments in clinical research for emerging therapies to examine their potential impact on improving patient outcomes in RCC
Commercial Support Acknowledgement
This activity is supported by an independent medical educational grant from GSK.
Copyright Information
Copyright © 2026 American Thoracic Society. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:
The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without written permission from American Thoracic Society.
Course summary
Faculty
Peter Dicpinigaitis, MD
Professor of Medicine
Albert Einstein College of Medicine
Director, Montefiore Cough Center
Bronx, NY
Disclosures
Consultant: GlaxoSmithKline, Hyfe, Merck, Nocion, Trevi
Lauren Eggert, MD
Associate Professor of Clinical Medicine
Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine
University of California San Francisco
San Francisco, CA
Disclosures
Consultant: AstraZeneca, GlaxoSmithKline, Nestwell Health, Regeneron
Speaker: GlaxoSmithKline, Sanofi
Planning Committee
Peter Dicpinigaitis, MD
Professor of Medicine
Albert Einstein College of Medicine
Director, Montefiore Cough Center
Bronx, NY
Disclosures
Consultant: GlaxoSmithKline, Hyfe, Merck, Nocion, Trevi
Lauren Eggert, MD
Associate Professor of Clinical Medicine
Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine
University of California San Francisco
San Francisco, CA
Disclosures
Consultant: AstraZeneca, GlaxoSmithKline, Nestwell Health, Regeneron
Speaker: GlaxoSmithKline, Sanofi
Emily Casabar, MSN, NP-C, AE-C
Stanford Health Care-Stanford Hospital
Stanford, CA
Disclosures
Consultant: Sanofi, Regeneron
Nicholas Klock, PA-C
Middlesex Health Urgent Care
Middletown, CT
Disclosures
Nothing to disclose
Melissa Glasner, MSc
Medical Writer
The France Foundation
Old Lyme, CT
Disclosures
Nothing to disclose
Amanda Noe
Senior Manager, Medical Education and Client Services
The France Foundation
Old Lyme, CT
Disclosures
Nothing to disclose
Erika Fox
Senior Project Manager
The France Foundation
Old Lyme, CT
Disclosures
Nothing to disclose
Patrick Harty, PhD
Medical Director
The France Foundation
Old Lyme, CT
Disclosures
Nothing to disclose
Content Reviewer
Patrick Harty, PhD
Medical Director
The France Foundation
Old Lyme, CT
It is the policy of the ATS to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. As an accredited CME provider, the ATS requires that its planners, reviewers and presenters comply with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. The ATS also requires specific disclosure of relationships with companies and organizations associated with tobacco or cannabis and prohibits or limits participation of faculty in official ATS activities, including CME, if any tobacco industry relationship or some types of cannabis industry relationships is present. The most recent policies regarding potential conflicts of interest as well as the mechanisms to mitigate or resolve such conflicts can be found here: COI Policy for Official ATS Activities (thoracic.org)
All relevant financial relationships have been reviewed and mitigated.
ACCREDITED PROVIDERS
Provided by the American Thoracic Society
Other CE credit provided by The France Foundation

Accreditation Statement – American Thoracic Society
The American Thoracic Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation
![]()
The American Thoracic Society designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Required Hardware/software
This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox and Safari browsers.
Additionally, this site and its activities are best viewed using the latest Operating System for your device.

Facebook
X
LinkedIn
Forward